LIVE VIRTUAL EVENT: Unlock the potential of biosimilars

Improve patient access and long-term healthcare system sustainability

10 May, 2021 · 9 am ET / 2pm BST / 3pm CET · 2-hour online event

Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare systems sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.

With mounting pressures testing current healthcare models to their limits, it has never been more important to take action to deliver long-term sustainability while ensuring patient access to medicines. Could biosimilars hold the key?

Join us for this exclusive panel event featuring insights and interviews with experts from patient groups, healthcare (pharmacist), data science, and the pharmaceutical industry as we discuss evolving barriers to biosimilars adoption worldwide and work toward solutions to improve access and affordability across the globe.

With thanks from the organizers, a Sandoz initiative in collaboration with Reuters Events

Speakers

Murray Aitken - Headshot
IQVIA Institute for Human Data Science - Logo

Murray Aitken Executive Director IQVIA Institute for Human Data Science

Read Bio
Pierre Bourdage - Headshot
Sandoz - Logo

Pierre Bourdage Global Head Biopharmaceuticals Sandoz

Read Bio

Antonella Cardone - Headshot
European Cancer Patient Coalition - Logo

Antonella Cardone Director European Cancer Patient Coalition

Read Bio

Rebecca Guntern - Headshot
Sandoz - Logo

Rebecca Guntern Head of Region Europe Sandoz

Read Bio

Claire Saxton - Headshot
Cancer Support Community (CSC) - Logo

Claire Saxton VP, Education and Outreach Cancer Support Community (CSC)

Read Bio
Christine Simmon - Headshot
Association for Accessible Medicines - Logo

Christine Simmon SVP Policy & Strategic Alliances Association for Accessible Medicines Executive Director Biosimilars Council

Read Bio



Robert Spina - Headshot
Sandoz US - Logo

Robert Spina Vice President, Marketing, Market Access & Patient Services Sandoz US

Read Bio
Prof. Dr. Arnold G. Vulto - Headshot
VuPEC - Logo

Prof. Dr. Arnold G. Vulto Hospital Pharmacist n.p.
Educator and consultant on Biopharmaceuticals / Biosimilars
VuPEC

Read Bio

Sue Saville - Headshot

Sue Saville Journalist Independent MODERATOR

Read Bio

Event Program

09:00am – 09:30am

Welcome Remarks

Sue Saville Journalist Independent MODERATOR

09:00am – 09:30am

Panel 1: 15-years of biosimilars in Europe: What lessons can we share? (45 mins)

  • Hear about the transformative impact of biosimilar medicines for patients and healthcare systems since the first launch
  • Discover measures that can help to drive savings and patient access to biosimilar medicines
  • Learn how innovative regulatory frameworks around clinical development can help shape biosimilar development – an opportunity ahead

Pierre Bourdage Global Head Biopharmaceuticals Sandoz

Antonella Cardone Director European Cancer Patient Coalition

Prof. Dr. Arnold G. Vulto Hospital Pharmacist n.p.
Educator and consultant on Biopharmaceuticals / Biosimilars
VuPEC

09:00am – 09:30am

Interview: The role of biosimilars in supporting post-Covid-19 healthcare systems

Rebecca Guntern Head of Region Europe Sandoz

09:00am – 09:30am

Interview: Building a sustainable market for biosimilars in the future

Murray Aitken Executive Director IQVIA Institute for Human Data Science

09:00am – 09:30am

Panel 2 - Unlocking the potential of biosimilars worldwide (45 mins)

  • Discover how biosimilars can help address the healthcare paradox by expanding patient access and creating healthcare savings
  • Hear about progress in addressing misinformation to improve biosimilar education for healthcare professionals and patients
  • Learn more about the ongoing regulatory and policy changes that can help address barriers to biosimilar uptake in the US, creating a more equitable healthcare system

Robert Spina Vice President, Marketing, Market Access & Patient Services Sandoz US

Christine Simmon SVP Policy & Strategic Alliances Association for Accessible Medicines Executive Director Biosimilars Council

Murray Aitken Executive Director IQVIA Institute for Human Data Science

Claire Saxton VP, Education and Outreach Cancer Support Community (CSC)

09:00am – 09:30am

Closing Remarks

Sue Saville Journalist Independent MODERATOR

Join 500 attendees from across the world, including:

  • Policy Makers
  • Payers
  • Pharma/Biotech Industry Execs
  • Physicians (organisations)
  • Patients (groups)
  • Other/Media

Here to help

Get in touch with the Reuters Events team